More and more cases of vaccine adverse effects, particularly irregular menstruation, are coming to light. After listening to Dr. Jane Ruby on the cellular alterations and permanence of the mRNA vaccines, I decided to do some research and found the following data from medical studies.
For context, ACE2, or angiotensin-converting enzyme 2, is what the SARS-CoV-2 virus’ spike protein binds to in order to enter cells. That spike protein attachment blocks the normal function of ACE2.
- SARS-CoV was studied 8 years ago.
- Animal trials for vaccine were stopped due to adverse reactions to mRNA and animals dying.
- The interaction of SARS-CoV spike protein with ACE2 was known.
- ACE2 dysregulation negatively impacts female fertility and pregnancy.
- Now SARS-CoV-2 has a higher affinity.
Further Data on the Clinical Trials of SARS-COV-2 with mRNA-1273
While the vaccines were pushed to production past clinical trials, the bias in reporting in order to do so is evident.
For one, the clinical trials are not even complete: “participants will be followed for 1 year after the second vaccination with scheduled blood collections.”
Rather than determine the safety profile before release, ITS SAFETY IS STILL BEING DETERMINED: “Additional testing in animals and ongoing T-cell analysis of clinical specimens will continue to define the safety profile of mRNA-1273.“
In clinical trials, adverse events are reported as solicited or unsolicited. Solicited means the data was intended to be collected by the registry. Unsolicited means the data was volunteered by the patient. In the Phase 1 trial above, the registry reports, “one participant in the 25-μg group was withdrawn because of an unsolicited adverse event, transient urticaria, judged to be related to the first vaccination.” She broke out in hives 5 days after the first dose (of 45 patients, she was 1 of 3 to not continue to second dose). IT IS UNSOLICITED BECAUSE THE REGISTRY WAS NOT INTENDING ON COLLECTING THAT DATA. They only wanted to note the specific efficacy of antibody and T-cell responses so they can say ‘it works’.
So, what was solicited? Of coarse, they only want to collect the minor adverse events, which were vast.
“After the first vaccination, solicited systemic adverse events were reported by 5 participants (33%) in the 25-μg group, 10 (67%) in the 100-μg group, and 8 (53%) in the 250-μg group; all were mild or moderate in severity (Figure 1 and Table S2). Solicited systemic adverse events were more common after the second vaccination and occurred in 7 of 13 participants (54%) in the 25-μg group, all 15 in the 100-μg group, and all 14 in the 250-μg group, with 3 of those participants (21%) reporting one or more severe events.”
These citations are not made to convince you that the vaccines do not work as a combatant against infection – they certainly do. But they do so much more than just fend off the virus. They have permanent, lasting effects on the body that we know negatively impacts female fertility. Not only is the data already displaying that, but is is likely far more prevalent due to reporting biases. While COVID cases would disregard underlying health conditions, even without a positive test confirmation of infection, vaccine data points to the health conditions and disregards the vaccine causation. Please consider your chances of the following:
- Being hospitalized by COVID-19: 0.34%
- Dying from COVID-19: 0.002%
- Vaccine Adverse Events: 0.07%. You are 35 times more likely to have an adverse reaction to the vaccine than to die from COVID-19.